Downloadable Slidesets

Share

Program Content

Activities

  • MCL: Risk Stratification and Treatment
    MCL: Prognostic and Predictive Biomarkers for Risk Stratification and Treatment Selection for Patients
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 12, 2022

    Expires: December 11, 2023

  • DLBCL: Biology and Initial Therapy
    DLBCL: Biology, Prognosis, and Selection of Initial Therapy
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 12, 2022

    Expires: December 11, 2023

  • DLBCL: Treatment of R/R Disease
    DLBCL: Management of Primary Refractory and Relapsed/Refractory Disease
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 12, 2022

    Expires: December 11, 2023

  • <i>EP</i>: MCL/DLBCL Therapy

    Express Points

    Aggressive B-Cell Lymphomas: Experts Discuss New Care Standards and Evolving Treatment Strategies

    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 16, 2022

    Expires: December 15, 2023

Faculty

cover img faculity

John P. Leonard, MD

Chief, Lymphoma/Myeloma Service
Division of Hematology and Oncology
Weill Medical College of Cornell University
New York Presbyterian Hospital
New York Weill Cornell Center
New York, New York

cover img faculity

John N. Allan, MD

Associate Professor of Clinical Medicine
Division of Hematology and Medical Oncology
Weill Cornell Medicine
New York, New York

cover img faculity

Laurie H. Sehn, MD, MPH

Chair, Lymphoma Tumour Group
BC Cancer
Vancouver, Canada

Provided by

ProCE Banner

Supporters

Bristol Myers Squibb

Genmab US Inc and AbbVie

Karyopharm Therapeutics Inc.

Regeneron Pharmaceuticals, Inc.